Next Article in Journal
An Uncommon Cause of Recurrent Presyncope, Dizziness, and Tachycardia: A Case Report of Diffuse, Adult-Onset Nesidioblastosis/Non-Insulinoma Pancreatogenous Hypoglycemia Syndrome (NIPHS)
Previous Article in Journal
Clinicopathological Outlines of Post-COVID-19 Pulmonary Fibrosis Compared with Idiopathic Pulmonary Fibrosis
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Human Regulatory Macrophages Derived from THP-1 Cells Using Arginylglycylaspartic Acid and Vitamin D3

Department of Life Science, Gachon University, Seongnam 13120, Gyeonggi-Do, Republic of Korea
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
Biomedicines 2023, 11(6), 1740; https://doi.org/10.3390/biomedicines11061740
Submission received: 17 May 2023 / Revised: 15 June 2023 / Accepted: 15 June 2023 / Published: 17 June 2023
(This article belongs to the Section Immunology and Immunotherapy)

Abstract

Regulatory macrophages (Mregs) are unique in that they have anti-inflammatory and immunosuppressive properties. Thus, treating inflammatory diseases using Mregs is an area of active research. Human Mregs are usually generated by culturing peripheral blood monocytes stimulated using a macrophage colony-stimulating factor with interferon (IFN)-γ. Herein, we generated Mregs with an elongated cell morphology from THP-1 cells that were stimulated with phorbol 12-myristate 13-acetate and cultured with both arginylglycylaspartic acid and vitamin D3. These Mregs regulated macrophage function, and respectively downregulated and upregulated the expression of pro-inflammatory and immunosuppressive mediators. They also expressed Mregs-specific markers, such as dehydrogenase/reductase 9, even when exposed to such inflammatory stimulants as IFN-γ, lipopolysaccharide, purified xenogeneic antigen, and xenogeneic cells. The Mregs also exerted anti-inflammatory and anticoagulatory actions in response to xenogeneic cells, as well as exerting immunosuppressive effects on mitogen-induced Jurkat T-cell proliferation. Our method of generating functional Mregs in vitro without cytokines is simple and cost-effective.
Keywords: regulatory macrophage; arginylglycylaspartic acid; vitamin D3; anti-inflammation; xenotransplantation regulatory macrophage; arginylglycylaspartic acid; vitamin D3; anti-inflammation; xenotransplantation

Share and Cite

MDPI and ACS Style

Pham, H.L.; Hoang, T.X.; Kim, J.Y. Human Regulatory Macrophages Derived from THP-1 Cells Using Arginylglycylaspartic Acid and Vitamin D3. Biomedicines 2023, 11, 1740. https://doi.org/10.3390/biomedicines11061740

AMA Style

Pham HL, Hoang TX, Kim JY. Human Regulatory Macrophages Derived from THP-1 Cells Using Arginylglycylaspartic Acid and Vitamin D3. Biomedicines. 2023; 11(6):1740. https://doi.org/10.3390/biomedicines11061740

Chicago/Turabian Style

Pham, Hoang Lan, Thi Xoan Hoang, and Jae Young Kim. 2023. "Human Regulatory Macrophages Derived from THP-1 Cells Using Arginylglycylaspartic Acid and Vitamin D3" Biomedicines 11, no. 6: 1740. https://doi.org/10.3390/biomedicines11061740

APA Style

Pham, H. L., Hoang, T. X., & Kim, J. Y. (2023). Human Regulatory Macrophages Derived from THP-1 Cells Using Arginylglycylaspartic Acid and Vitamin D3. Biomedicines, 11(6), 1740. https://doi.org/10.3390/biomedicines11061740

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop